Valuation : OrganiGram Holdings Inc

Market Cap 224M 162M 139M 131M 120M 15.33B 225M 1.55B 601M 7.85B 609M 595M 25.01B P/E 2026 *
1.97x
P/E 2027 * 19.9x
Enterprise Value 224M 162M 139M 131M 120M 15.33B 225M 1.55B 601M 7.85B 609M 595M 25.01B EV / Sales 2026 *
0.64x
EV / Sales 2027 * 0.49x
Free-Float
68.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Operating Officer - 19/08/2026
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.06%-9.65% - - 162M
+0.86%+1.39%+9.36%+227.54% 357M
+0.63%-3.64%-30.26%-23.92% 162M
+0.51%0.00%+15.70%+99.00% 142M
+5.68%+13.41%-36.30%-53.03% 94.49M
+1.80%-0.82%-37.18%-45.53% 65.63M
Average +1.40%+0.85%-15.74%+40.81% 164.33M
Weighted average by Cap. +0.98%+0.40%-6.33%+101.58%

Financials

2026 *2027 *
Net sales 350M 253M 218M 205M 187M 23.95B 351M 2.43B 939M 12.27B 951M 930M 39.07B 458M 332M 285M 268M 245M 31.37B 460M 3.18B 1.23B 16.07B 1.25B 1.22B 51.17B
Net income 128M 92.91M 79.91M 75.15M 68.6M 8.79B 129M 891M 344M 4.5B 349M 341M 14.33B 8.1M 5.87M 5.04M 4.74M 4.33M 555M 8.13M 56.25M 21.74M 284M 22.03M 21.55M 905M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!